Biomarkers for non-invasive detection and classifform-control form-control ication of prostate cancer
Three new biomarkers for the prognosis, stratification and cancer monitoring have been identified: PCA3, MRC2, and S100A4. These biomarkers could be detected by non-invasive methods, such as liquid biopsy, and be used as a co
Patents for licensing